BioSpace News Archive

Valet Health, a healthcare digital marketing company, is proud to announce a strategic partnership with DataBiologics, a robust data collection platform for tracking patient outcomes in orthobiologics and minimally invasive procedures.

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, will be added as a member of the US small-cap Russell 2000® Index. The addition will be effective after the US market opens on June 29, 2020 as part of the 2020 Russell US Indexes annual reconstitution. Inclusion in the Russell 2000® Index, which remains

Canadian health and wellness brand, Revelox plans to expand their selling model after a successful round of meetings at the historic virtual ECRM conference.

NuGenerex Immuno-Oncology (NGIO) is focused on modulation of the immune system to develop Ii-Key peptide vaccines for the treatment and prevention of cancer and infectious diseases NGIO is now a stand-alone public company with plans to list shares on Nasdaq MIRAMAR, Fla., June 26, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology is pleased to announce its inaugural shareholder meeting as a public stand-alone company. The company will introduce the management team and its world class board

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, announced upcoming changes to its Board of Directors.

ERC Belgium, a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer, has announced that it has submitted to the EMA its Marketing Authorization Application for conditional approval of its lead product SITOIGANAP to treat recurrent glioblastoma.

Transparency Market Research has published a new report titled, “Pediatric Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

The global orthopedic orthotics market was valued approximately at US$ 3.4 Bn in 2017 and is projected to expand at a cumulative annual growth rate of over 5.5% from 2018 to 2026, according to a new report published by Transparency Market Research titled ‘Orthopedic Orthotics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’

The global helicobacter pylori non-invasive testing market was valued at approximately US$ 518.0 Mn in 2017 and is projected to register a compounded annual growth rate of over 3.99% from 2018 to 2026

Transparency Market Research has published a new report titled, “Extracorporeal CO2 Removal Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global extracorporeal CO2 removal market was valued at US$ 50.0 Mn in 2017 and is projected to expand at a CAGR of 6.0% from 2018 to 2026.